Most Accessed Articles

Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer

, 2018; 18(4): 306-327.

Heena Singla, Anjana Munshi*, Raja Paramjit Singh Banipal and Vinod Kumar*

DOI: 10.2174/1568009617666170623122213

Tunneling Nanotubes: A Versatile Target for Cancer Therapy

, 2018; 18(6): 514-521.

Pragyaparamita Sahu, Soumya Ranjan Jena and Luna Samanta*

DOI: 10.2174/1568009618666171129222637

Towards Prevention of Ovarian Cancer

, 2018; 18(6): 522-537.

Aus Tariq Ali*

DOI: 10.2174/1568009618666180102103008

Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges

, 2018; 18(3): 222-230.

J. Barroca-Ferreira, J.P. Pais, M.M. Santos, A.M. Goncalves, I.M. Gomes, I. Sousa, S.M. Rocha, L.A. Passarinha and C.J. Maia*

DOI: 10.2174/1568009617666170427103732

HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles

, 2017; 17(7): 637-649.

Sarah L. Sammons, Donna L. Topping and Kimberly L. Blackwell*

DOI: 10.2174/1568009617666170330120452

Webmaster Contact:
Copyright © 2018 Bentham Science